| The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ-TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling M Suljagic, PG Longo, S Bennardo, E Perlas, G Leone, L Laurenti, ... Blood, The Journal of the American Society of Hematology 116 (23), 4894-4905, 2010 | 177 | 2010 |
| Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL S Iacovelli, E Hug, S Bennardo, M Duehren-von Minden, S Gobessi, ... Blood, The Journal of the American Society of Hematology 125 (10), 1578-1588, 2015 | 63 | 2015 |
| Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells M Suljagic, L Laurenti, M Tarnani, M Alam, SN Malek, DG Efremov Leukemia 24 (12), 2063-2071, 2010 | 30 | 2010 |
| The predictive significance of Metastasis-Associated in Colon Cancer-1 (MACC1) in primary breast cancer J Prguda-Mujic, K Milde-Langosch, V Mueller, M Suljagic, J Coric, D Ler Annals of Clinical & Laboratory Science 48 (2), 191-196, 2018 | 11 | 2018 |
| Metformin and thymoquinone synergistically inhibit proliferation of imatinib-resistant human leukemic cells U Glamoclija, L Mahmutovic, E Bilajac, V Soljic, K Vukojevic, M Suljagic Frontiers in pharmacology 13, 867133, 2022 | 10 | 2022 |
| Autoencoder-aided measurement of concentration from a single line of speckle M Karamehmedović, K Šehić, B Dammann, M Suljagić, ... Optics Express 27 (20), 29098-29123, 2019 | 7 | 2019 |
| F, Sica S, Laurenti L, Wang H, Cornall RJ, Clarke SH, Croce CM, Bertoni F, Jumaa H, Efremov DG (2015) Two types of BCR interactions are positively selected during leukemia … S Iacovelli, E Hug, S Bennardo, M Duehren-von Minden, S Gobessi, ... Blood 125 (10), 1578-1588, 0 | 7 | |
| Curcumin decreases viability and inhibits proliferation of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cell lines E Bilajac, L Mahmutović, U Glamočlija, A Osmanović, ... Metabolites 13 (1), 58, 2022 | 5 | 2022 |
| Characterization of solvents and optimization of stability and solubility of bioactive compounds used in lymphoma cell culture treatments A Adilovic, L Mahmutović, E Huseinbegović, M Suljagic Periodicals of Engineering and Natural Sciences 8 (4), 2553-2563, 2020 | 4 | 2020 |
| Urine qRT-PCR assay as a screening tool for the detection of congenital human cytomegalovirus infection of infants E Huseinbegović, D Ler, M Suljagic Periodicals of Engineering and Natural Sciences 8 (4), 1951-1958, 2020 | 1 | 2020 |
| Troubleshooting of RNA isolation methods in Papanicolaou HPV cervical smears T Becirevic, M Suljagic, D Ler Periodicals of Engineering and Natural Sciences 8 (4), 1959-1967, 2020 | 1 | 2020 |
| The Nature of the Antigen Determines Leukemia Development and Behavior in the Eμ-TCL1 Transgenic Mouse Model of CLL S Bennardo, S Iacovelli, S Gobessi, M Suljagic, D Bilbao, J Eckl-Dorna, ... Blood 120 (21), 181, 2012 | 1 | 2012 |
| Active-subspace analysis of speckle patterns M Karamehmedović, M Suljagić, E Karamehmedović 17th Electromagnetic and Light Scattering Conference, Texas A&M University …, 2018 | | 2018 |
| Targeting survival pathways in leukemic cells through synergism of metformin and thymoquinone U Glamoclija, M Suljagic FEBS JOURNAL 283, 167-167, 2016 | | 2016 |
| Two types of BCR interactions are positively selected during leukemia development in the Eµ-TCL1 transgenic mouse model of CLL RJ Wang, SH Clarke, CM Croce10, F Bertoni, H Jumaa, DG Efremov | | 2015 |
| Natural quinones and quinone analogues in cancer therapy MS Una Glamoclija Pharmacia 15 (1), 131-136, 2015 | | 2015 |
| TARGETING THE SURVIVAL PATHWAYS OF CANCER CELLS WITH METFORMIN AND THYMOQUINONE: ROLE OF MITOCHONDRIA AND ROS FORMATION MS Una Glamoĉlija REDOX MEDICINE 3 (1), p.95, 2015 | | 2015 |
| Loss of PHLPP1 Tumor Suppressor Enhances BCR-induced Pro-survival Signalling in Chronic Lymphocytic Leukemia DGE Mirza Suljagic J. Res. Pharm. Sci., 46-47, 2014 | | 2014 |
| The Syk Inhibitor R788 (FosD) Inhibits Tumor Growth in the TCL1 Transgenic Mouse Model of CLL by Blocking Antigen-Dependent BCR Signaling. M Suljagic, PG Longo, L Laurenti, DG Efremov Blood 114 (22), 887, 2009 | | 2009 |
| Chronic Lymphocytic Leukemia B-Cells Lack or Express Markedly Reduced Levels of the Phosphatase PHLPP, Which Regulates B-Cell Receptor Induced AKT Activation. M Suljagic, L Laurenti, M Alam, PG Longo, SN Malek, DG Efremov Blood, The Journal of the American Society of Hematology 112 (11), 2080-2080, 2008 | | 2008 |
Dimitar EfremovICGEBVerified email at icgeb.org
